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Brain mitochondriaSulﬁte oxidase (SO) deﬁciency is biochemically characterized by the accumulation of sulﬁte, thiosulfate
and S-sulfocysteine in tissues and biological ﬂuids of the affected patients. The main clinical symptoms include
severe neurological dysfunction and brain abnormalities, whose pathophysiology is still unknown. The present
study investigated the in vitro effects of sulﬁte and thiosulfate on mitochondrial homeostasis in rat brain mito-
chondria. It was veriﬁed that sulﬁte per se, but not thiosulfate, decreased state 3, CCCP-stimulated state and re-
spiratory control ratio in mitochondria respiring with glutamate plus malate. In line with this, we found that
sulﬁte inhibited the activities of glutamate and malate (MDH) dehydrogenases. In addition, sulﬁte decreased
the activity of a commercial solution of MDH, that was prevented by antioxidants and dithiothreitol. Sulﬁte
also induced mitochondrial swelling and reduced mitochondrial membrane potential, Ca2+ retention capacity,
NAD(P)H pool and cytochrome c immunocontent when Ca2+ was present in the medium. These alterations
were prevented by ruthenium red, cyclosporine A (CsA) and ADP, supporting the involvement of mitochondrial
permeability transition (MPT) in these effects. We further observed that N-ethylmaleimide prevented the
sulﬁte-elicited swelling and that sulﬁte decreased free thiol group content in brain mitochondria. These ﬁndings
indicate that sulﬁte acts directly onMPT pore containing thiol groups. Finally, we veriﬁed that sulﬁte reduced cell
viability in cerebral cortex slices and that this effect was prevented by CsA. Therefore, it may be presumed that
disturbance of mitochondrial energy homeostasis and MPT induced by sulﬁte could be involved in the neuronal
damage characteristic of SO deﬁciency.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Sulﬁte, thiosulfate and S-sulfocysteine accumulate in tissues and bi-
ological ﬂuids of patients affected by sulﬁte oxidase (SO) deﬁciency, an
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55 51 3308 5540.deﬁciency of the enzymeSOor fromdefects in the biosynthetic pathway
of its essential cofactor, amolybdenum containing pterinmolecule [1,2].
SO is a mitochondrial enzyme that catalyzes the ﬁnal step in the oxida-
tive degradation of the sulfur containing amino acids cysteine and me-
thionine, playing also an important role in detoxifying exogenously
supplied sulﬁte, since this metabolite may be generated from com-
pounds that are used in food andpharmaceutical industries as preserva-
tives and antimicrobial agents [3–5].
Both forms of SO deﬁciency are clinically characterized by progres-
sive neurological dysfunction, severe neonatal seizures, lens subluxa-
tion, axial hypotonia, limb hypertonicity and failure to thrive, resulting
often in early childhood death [1,2,6]. Neuropathological studies reveal
severe encephalopathy with neuronal loss and demyelination in the
cerebral white matter accompanied by gliosis and diffuse spongiosis.
Marked atrophy of the cerebral cortex, basal ganglia, thalami, as well
as myelin loss in the cerebellum are also reported [1,6–8]. Furthermore,
MRI scans show hypoplasia of the corpus callosum, basal ganglia
and brainstem, and cystic changes and calciﬁcations in the basal ganglia
[1,9].
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affected by SO deﬁciency, the biochemical basis of the pathogenesis
characteristic of this disorder is still unclear. Nevertheless, there are ev-
idences that accumulation of sulﬁte and its derivatives induces oxida-
tive stress [10,11] and disturbs mitochondrial function [12,13] in rat
brain, which may contribute for the clinical ﬁndings observed in affect-
ed patients.
Calcium homeostasis dysregulation has been suggested to play an
important role in the pathophysiology of neurodegenerative disorders
that are associatedwith excitotoxicity, bioenergetic dysfunction and ox-
idative stress [14–16]. Under such pathological conditions, excessive
Ca2+ uptake by the mitochondrion directly results in organelle dys-
function characterized by exacerbated reactive oxygen species forma-
tion, dissipation of the membrane potential, altered redox potential
and opening of the mitochondrial permeability transition (MPT) pore,
which may lead to cell death [17,18].
Since the effects of sulﬁte and thiosulfate on mitochondrial function
are not totally elucidated, we examined the in vitro effects of these com-
pounds on ADP-stimulated state (state 3), resting state (state 4) and
carbonyl cyanide m-chlorophenyl hydrazine (CCCP)-stimulated state
(uncoupled state) of mitochondrial respiration, the respiratory control
ratio (RCR), as well as the activities of glutamate, malate and α-
ketoglutarate dehydrogenases in brain mitochondrial preparations
from young rats. Considering that a mitochondrial dysfunction can
compromise Ca2+ buffering system and that this may be involved in
the pathogenesis of SO deﬁciency, we also investigated the inﬂuence
of sulﬁte in the presence ofmicromolar concentrations of Ca2+ onmito-
chondrial membrane potential, swelling, Ca2+ retention capacity, ma-
trix NAD(P)H content, membrane protein thiol group content and
cytochrome c release. We further tested the effect of sulﬁte on cell via-
bility in cerebral cortex slices.
2. Material and methods
2.1. Reagents
All chemicals, including sodium sulﬁte, sodium thiosulfate, glutamic
acid and malic acid, were purchased from Sigma (St. Louis, MO, USA),
except for calcium green-5N that was obtained from Molecular Probes,
Invitrogen (Carlsbad, CA), and mouse anti-cytochrome c monoclonal
antibody and anti-mouse IgG peroxidase-linked antibody from Abcam
(Cambridge, UK). Sulﬁte and thiosulfate were dissolved in the buffer
used for each technique and the pHwas adjusted to 7.4 immediately be-
fore the experiments. The ﬁnal concentrations of these metabolites in
the incubation medium ranged from 1 to 500 μM.
2.2. Animals
Thirty-day-old male Wistar rats, obtained from the Central Animal
House of the Department of Biochemistry, ICBS, Universidade Federal do
Rio Grande do Sul, Porto Alegre, RS, Brazil, were used. The animals were
maintained on a 12:12 h light/dark cycle (lights on 07:00–19:00 h) in
air conditioned constant temperature (22 ± 1 °C) colony room, with
free access to water and 20% (w/w) protein commercial chow (SUPRA,
Porto Alegre, RS, Brazil). The experimental protocol was approved by
the Ethics Committee for Animal Research of the Universidade Federal
do Rio Grande do Sul, Porto Alegre, Brazil, and followed the NIH Guide
for the Care and Use of Laboratory Animals (NIH publication 85-23, re-
vised 1996). All efforts were made to minimize the number of animals
used and their suffering.
2.3. Preparation of mitochondrial fractions
Forebrain and livermitochondriawere isolated from 30-day-old rats
as previously described [19] with slight modiﬁcations [20]. Animals
were killed by decapitation, had their brain and liver rapidly removedand put into ice-cold isolation buffer containing 225 mM mannitol,
75 mM sucrose, 1 mM EGTA, 0.1% bovine serum albumin (BSA; fatty
acid free) and 10 mM HEPES, pH 7.2. Regarding to the brain, the cere-
bellum, pons, medulla and olfactory bulbs were removed and the re-
maining material was used as the forebrain. Both tissues were cut
into small pieces using surgical scissors, extensively washed to remove
blood and homogenized 1:10 in a Dounce homogenizer using both a
loose-ﬁtting and a tight-ﬁtting pestle. The homogenatewas centrifuged
for 3 min at 2000 g. After centrifugation, the supernatant was again
centrifuged for 8 min at 12,000 g. The pellet was suspended in isolation
buffer containing 10 μL of 10% digitonin and centrifuged for 8 min at
12,000 g. The ﬁnal pellet containing the mitochondria was gently
washed and suspended in isolation buffer devoid of EGTA, at an ap-
proximate protein concentration of 20 mg·mL−1. For the measure-
ment of malate dehydrogenase (MDH), glutamate dehydrogenase
(GDH) and α-ketoglutarate dehydrogenase (α-KGDH) activities, mito-
chondrial preparations were submitted to a pre-incubation at 37 °C for
30 min in the absence or presence of sulﬁte. All experiments were per-
formed in mitochondria with high RCR values, guarantying the full in-
tegrity of the preparations.
We carried out parallel experiments with various blanks (controls)
in the presence or absence of sulﬁte and thiosulfate, and also with or
without mitochondrial preparations in the incubation medium in
order to detect any interference (artifacts) in the techniques utilized
to measure the mitochondrial parameters.
2.4. Determination of mitochondrial respiratory parameters by oxygen
consumption
Oxygen consumption rate was measured according to Amaral
et al. [21] using a Clark-type electrode in a thermostatically con-
trolled (37 °C) and magnetically stirred incubation chamber using
glutamate plus malate (2.5 mM each), succinate (5 mM) plus rote-
none (2 μg·mL−1), α-ketoglutarate (5 mM) or pyruvate plus malate
(2.5 mM each) as substrates. Sulﬁte or thiosulfate was added to the re-
action medium consisted of 0.3 M sucrose, 5 mMMOPS, 5 mM potassi-
um phosphate, 1 mM EGTA and 0.1% BSA, pH 7.4, and mitochondrial
preparations (0.75 mg protein·mL−1 using glutamate plus malate,
α-ketoglutarate or pyruvate plus malate and 0.5 mg protein·mL−1
using succinate). State 3 respiration was measured after the addition
of 1 mM ADP to the incubation medium. In order to measure resting
(state 4) respiration, 1 μg·mL−1 oligomycin A was added to the incu-
bation medium. The respiratory control ratio (RCR: state 3/state 4)
was then calculated. The uncoupled state was induced by the addition
of the classical uncoupler CCCP (1 μM). States 3, 4 and CCCP-induced
state were calculated as nmol O2 consumed·min−1·mg protein−1
and the results were expressed as percentage of control.
2.5. Determination of glutamate dehydrogenase (GDH) activity
GDH activity was assayed according to Colon et al. [22]. The reaction
mixture contained mitochondrial preparations (60 μg protein·mL−1),
50mMtriethanolamine buffer, pH 7.8, 2.6mMEDTA, 105mMammoni-
um acetate, 0.2 mM NADH, 10 mM α-ketoglutarate and 1.0 mM ADP.
The reduction of NADH absorbance was monitored spectrophotometri-
cally at 340 nm. GDH activity was calculated as μmol NADH·min−1·mg
protein−1 and expressed as percentage of control.
2.6. Determination of malate dehydrogenase (MDH) activity
MDH activity was measured according to Kitto [23]. The incubation
medium consisted of mitochondrial preparations (7 μg protein·mL−1),
10 μM rotenone, 0.1% Triton X-100, 0.14 mM NADH, 0.3 mM oxaloace-
tate and 50mM potassium phosphate, pH 7.4. MDH activity was deter-
mined following the reduction of NADH ﬂuorescence at wavelengths of
excitation and emission of 366 and 450 nm, respectively. MDH activity
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percentage of control.
2.7. Determination of α-ketoglutarate dehydrogenase (α-KGDH) complex
activity
The activity ofα-KGDH complex was evaluated according to Lai and
Cooper [24] and Tretter and Adam-Vizi [25] with some modiﬁcations.
The incubation medium contained mitochondrial preparations
(0.25 mg protein·mL−1), 1 mM MgCl2, 0.2 mM thiamine pyrophos-
phate, 0.4 mMADP, 10 μM rotenone, 0.2mMEGTA, 0.12 mM coenzyme
A-SH, 1 mM α-ketoglutarate, 2 mM NAD+, 0.1% Triton X-100 and
50 mM potassium phosphate, pH 7.4. The reduction of NAD+ was re-
corded at wavelengths of excitation and emission of 366 and
450 nm, respectively. α-KGDH activity was calculated as nmol
NADH·min−1·mg protein−1 and expressed as percentage of control.
2.8. Determination of mitochondrial membrane potential (ΔΨm)
The ΔΨmwas estimated according to Akerman and Wikstrom [26]
and Figueira et al. [27], following the ﬂuorescence of the cationic dye
SafraninO (5 μM)on aHitachi F-4500 spectroﬂuorometerwithmagnet-
ic stirring at an excitation and emission of 495 and 586 nm, respectively,
using 2.5 mM glutamate plus 2.5 mM malate as substrates. Mitochon-
drial preparations (0.5 mg protein·mL−1) were incubated at 37 °C
with sulﬁte in 5 mMHEPES buffer, pH 7.2, containing 150 mM potassi-
um chloride, 5 mM magnesium chloride, 0.015 mM EGTA, 5 mM
potassium phosphate, 0.01% BSA and 1 μg·mL−1 oligomycin A. CaCl2
(10–30 μM)was added to the reactionmedium 50 s after the beginning
of the assay. In some experiments, themitochondrial preparationswere
incubated with cyclosporin A (CsA; 1 μM), ADP (300 μM) or ruthenium
red (RR; 1 μM). In the end of each measurement, maximal depolariza-
tion was induced by 1 μM carbonyl cyanide-4-(triﬂuoromethoxy)
phenylhydrazone (FCCP). The results are shown as traces representing
ﬂuorescence arbitrary units (FAU).
2.9. Determination of mitochondrial swelling
Mitochondrial swelling was assessed by measuring light scattering
changes on a Hitachi F-4500 spectroﬂuorometer with magnetic stirring
operating at excitation and emission of 540 nm, using 2.5 mM gluta-
mate plus 2.5 mM malate as substrates. Mitochondrial preparations
(0.5 mg protein·mL−1) were incubated at 37 °C with 500 μM sulﬁte
in 5 mM HEPES buffer, pH 7.2, containing 150 mM potassium chloride,
5 mM magnesium chloride, 0.015 mM EGTA, 5 mM potassium phos-
phate, 0.01% BSA and 1 μg·mL−1 oligomycin A. CaCl2 (40 μM) was
added to the reaction medium 50 s after the beginning of the assay. In
some experiments the mitochondrial preparations were incubated
with CsA (1 μM), ADP (300 μM), RR (1 μM), N-acetylcysteine (NAC;
1 mM), catalase (CAT; 500 U·mL−1), melatonin (MEL; 1 mM), coen-
zyme Q10 (CoQ; 50 μM), triﬂuoperazine (TFZ; 20 μM), chlorpromazine
(CP; 20 μM), quinacrine (QUIN; 200 μM), dithiothreitol (DTT; 3 mM)
or N-ethylmaleimide (NEM; 20 μM). In the end of each measurement,
maximal swelling was induced by the addition of alamethicin
(40 μg·mL−1), a pore-forming compound. The results are shown as
traces representing FAU.
2.10. Mitochondrial Ca2+ retention capacity
Ca2+ retention capacity was determined in mitochondria incubated
at 37 °C with 500 μM sulﬁte in 5 mM HEPES buffer, pH 7.2, containing
150 mM potassium chloride, 5 mM magnesium chloride, 0.015 mM
EGTA, 5 mM potassium phosphate, 0.01% BSA, 30 μM ADP, 1 μg·mL−1
oligomycin A, 2.5mMglutamate and2.5mMmalate, and supplemented
with 0.2 μMcalcium green-5N. A low concentration of ADP (30 μM)was
present in the incubation medium to achieve more consistentmitochondrial Ca2+ uptake responses [28]. Levels of external free
Ca2+ were measured by recording the ﬂuorescence of calcium green-
5N on a temperature-controlled Hitachi F-4500 spectroﬂuorometer
with magnetic stirring operating at excitation and emission wave-
lengths of 506 and 532 nm, respectively, and slit width of 5 nm. Twomi-
nutes after the addition of mitochondria (0.5 mg·mL−1) to the cuvette,
20 μM CaCl2 was added. In some experiments, the mitochondrial prep-
arationswere incubatedwith CsA (1 μM) andADP (300 μM). The results
are shown as traces representing FAU.
2.11. Determination of NAD(P)H ﬂuorescence
Mitochondrial matrix NAD(P)H autoﬂuorescence was measured at
37 °C on a Hitachi F-4500 spectroﬂuorometer withmagnetic stirring op-
erating at an excitation wavelength of 366 nm and emission wavelength
of 450 nm, using 2.5 mM glutamate plus 2.5 mM malate as substrates.
Mitochondrial preparations (0.5 mg protein·mL−1) were incubated at
37 °C with 500 μM sulﬁte in 5 mM HEPES buffer, pH 7.2, containing
150 mM potassium chloride, 5 mM magnesium chloride, 0.015 mM
EGTA, 5mMpotassiumphosphate, 0.01% BSA and 1 μg·mL−1 oligomycin
A. CaCl2 (20 μM)was added to the reactionmedium 50 s after the begin-
ning of the assay. In some experiments, the mitochondrial preparations
were incubated with CsA (1 μM), ADP (300 μM) or RR (1 μM). In the
end of the measurements, maximal NAD(P)H oxidation was induced by
1 μM FCCP. The results are shown as traces representing FAU.
2.12. Determination of mitochondrial membrane protein thiol group
content
The mitochondrial membrane protein thiol content in rat brain was
measured according to Kowaltowski et al. [29] with slight modiﬁca-
tions. After mitochondrial swelling experiments, the medium was cen-
trifuged at 15,000 g for 2 min in order to sediment the mitochondria.
The resultant pellet was resuspended in 5 mM HEPES buffer, pH 7.2,
containing 150 mM potassium chloride, 5 mM magnesium chloride,
0.015 mM EGTA, 5 mM potassium phosphate and 0.01% BSA and sub-
mitted to three subsequent freeze-thawing procedures to release ma-
trix proteins. A centrifugation was then carried out during 2 min at
15,000 g. The pellet was treated with 200 μL of 6.5% trichloroacetic
acid and centrifuged at 15,000 g during 2 min in order to precipitate
the proteins. This procedure was repeated twice. The ﬁnal pellet was
suspended in 200 μL of a medium containing 0.5 mM EDTA and 0.5 M
Tris, pH 8.3. Three hundred and forty micrograms of protein were
added to 1 mL of a solution containing 100 μM 5,5′-dithio-bis(2-
nitrobenzoic acid), 0.5 mM EDTA and 0.5 M Tris, pH 8.3. Absorption
was measured at 412 nm. Thiol group content was calculated as nmol
5-thio-2-nitrobenzoic acid (TNB)·mg protein−1 and expressed as per-
centage of control.
2.13. Cytochrome c immunocontent measurement
After mitochondrial swelling experiments, the medium was centri-
fuged at 12,000 g for 10 min in order to sediment the mitochondria.
The resultant pellet was resuspended in 1 × RIPA buffer and centrifuged
(10,000 g for 5 min at 4 °C). Equal amounts of protein (30 μg per well)
for each sample prepared in Laemmli-sample buffer (62.5 mM Tris–
HCl, pH 6.8, 1% (w/v) SDS, 10% (v/v) glycerol) were fractionated by
SDS-PAGE and electro-blotted onto nitrocellulose membranes with
Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell, Bio-Rad (Hercu-
les, CA, USA). Protein loading and electro-blotting efﬁciency were veri-
ﬁed through Ponceau S staining, and the membrane was washed with
Tween–Tris buffered saline (Tris 100 mM, pH 7.5, 0.9% NaCl and 0.1%
Tween-20).Membraneswere incubated for 20min at room temperature
in SNAP i.d.® 2.0 Protein Detection System Merck Millipore (Billerica,
MA, USA) with cytochrome c primary antibody (1:500 dilution range)
and washed with TTBS afterwards. Anti-mouse IgG peroxidase-linked
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in SNAP (1:5000 dilution range), washed again and the immunoreactiv-
ity was detected by enhanced chemiluminescence using Supersignal
West Pico Chemiluminescent kit from Thermo Scientiﬁc (Luminol/
Enhancer and Stable Peroxide Buffer). Densitometric analysis of the
ﬁlms was performed with Image J software. Blots were developed to
be linear in the range used for densitometry. The resultswere expressed
as percentage of control.
2.14. Brain slice preparation
Animals were killed by decapitation and their brains were removed.
Four hundredmicrometerswide cerebral cortex sliceswere obtained by
using a McIlwain tissue chopper. The slices were washed with 500 μL
Hanks' balanced salt solution (HBSS) containing 137 mM NaCl,
0.63 mM Na2HPO4, 4.17 mM NaHCO3, 5.36 mM KCl, 0.44 mM KH2PO4,
0.41 mM MgSO4, 5.55 mM glucose, 0.49 mM MgCl2 and 1.26 mM
CaCl2 and pre-incubated at 37 °C for 3 h with sulﬁte at the presence of
5% CO2. The pH was maintained at 7.4.Fig. 1. Effect of sulﬁte on (A) ADP-stimulated respiration (state 3), (B) resting respiration (sta
(RCR) using brain mitochondria supported by glutamate plus malate (GM), succinate (SUC)
added at the beginning of incubation to the reaction medium containing the mitochondrial
using SUC). (E) Representative curve of oxygen concentration in the absence (trace a) or prese
indicate the addition of ADP, oligomycin and CCCP. The slopes of the curve during states 3 and 4
four independent experiments (animals) and are expressed as percentage of controls (Controls:
41.4 ± 6.54; PM: 124 ± 12.5; (B) State 4 [nmol O2·min−1·mg of protein−1]: GM: 8.43 ± 1.54
of protein−1]: GM: 85.9 ± 13.9; SUC: 67.0 ± 6.46; α-KG: 27.5 ± 2.59; PM: 124 ± 35.2;
*P b 0.05, ** P b 0.01, *** P b 0.001, compared to controls (Duncan multiple range test).2.15. MTT reduction
Cell viability was determined in cerebral cortex slices by measuring
the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) to a dark violet formazan product [30]. After pre-
incubation, the slices were washed twicewith 500 μL HBSS. MTT reduc-
tion assay was performed in plates containing 300 μL HBSS and the re-
action was started with the addition of 0.5 mg·mL−1 MTT. After
45min incubation at 37 °C themediumwas removed and the slices dis-
solved in dimethyl sulphoxide. The rate ofMTT reductionwasmeasured
spectrophotometrically at a wavelength of 570 nm and a reference
wavelength of 630 nm. Results were compared to control samples to
which 100% viability was attributed.2.16. Protein determination
Protein contentwasmeasured by themethod of Bradford [31], using
bovine serum albumin as a standard.te 4), (C) CCCP-stimulated respiration (uncoupled state) and (D) respiratory control ratio
, α-ketoglutarate (α-KG) and pyruvate plus malate (PM). Sulﬁte (100 or 500 μM) was
preparations (0.75 mg protein·mL−1 using GM, α-KG or PM and 0.5 mg protein·mL−1
nce of sulﬁte (500 μM) (trace b) using brain mitochondria supported by GM. The arrows
were used for direct calculation of RCR. Values aremeans± standard deviation for three to
(A) State 3 [nmol O2·min−1·mgof protein−1]: GM: 80.7± 12.7; SUC: 72.2± 6.45;α-KG:
; SUC: 13.5 ± 0.87; α-KG: 11.6 ± 0.99; PM: 9.09 ± 0.50; (C) CCCP [nmol O2·min−1·mg
(D) RCR: GM: 9.67 ± 0.98; SUC: 5.32 ± 0.19; α-KG: 3.56 ± 0.31; PM: 13.7 ± 2.12).
Fig. 2. Effect of sulﬁte on (A) glutamate dehydrogenase (GDH), (B)malate dehydrogenase (MDH) and (C)α-ketoglutarate dehydrogenase (α-KGDH) activities in brainmitochondria. Sul-
ﬁte (1–500 μM)was added to the reaction medium containing the mitochondrial preparations and incubated for 30 min. Values are means± standard deviation for four to six indepen-
dent experiments (animals) and are expressed as percentage of controls. (Controls: (A) GDH [μmol NADH·min−1·mg protein−1]: 74.49 ± 4.470; (B) MDH [μmol NADH·min−1·mg
protein−1]: 6377 ± 570.5; (C) α-KGDH [nmol NADH·min−1·mg protein−1]: 54.17 ± 11.04). *P b 0.05, *** P b 0.001, compared to controls (Duncan multiple range test).
Fig. 3. Effect of sulﬁte on the activity of a commercial solution of malate dehydrogenase
(MDH). Sulﬁte (500 μM) was added do the reaction medium containing puriﬁed
MDH and incubated for 30 min. In some experiments, melatonin (MEL; 1500 μM),
catalase (CAT; 500 U·mL−1) or dithiothreitol (DTT; 5 mM) was co-incubated with
500 μM sulﬁte. Values are means ± standard deviation for three to ﬁve independent ex-
periments (animals) and are expressed as percentage of controls. (Control: MDH
[mmol NADH·min−1·mg protein−1]: 3822± 506.1). *** P b 0.001, compared to control;
###P b 0.001, compared to sulﬁte (Duncan multiple range test).
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Results are presented as mean ± standard deviation. Assays were
performed in duplicate or triplicate and the mean was used for statisti-
cal analysis. Data were analyzed by one-way ANOVA, followed by the
post hoc Duncanmultiple range testwhen Fwas signiﬁcant. Only signif-
icant F values are shown in the text. Differences between groups were
rated signiﬁcant at P b 0.05. All analyses were carried out using the
Statistical Package for the Social Sciences (SPSS) software.
3. Results
3.1. Sulﬁte alters oxygen consumption in brain mitochondria supported by
glutamate plus malate
First, we determined the effect of sulﬁte and thiosulfate on brainmi-
tochondrial oxygen consumption using glutamate plus malate, succi-
nate, α-ketoglutarate or pyruvate plus malate as substrates. Fig. 1
shows that brain mitochondria incubated under our experimental
conditionswere well functioning, as indicated by the higher respiratory
rates observed in the presence of ADP (state 3) relatively to those ob-
tained after the addition of the ATP synthase inhibitor oligomycin
A (state 4). It was veriﬁed that sulﬁte decreased state 3 respiration
[F(2,9) = 15.546, P b 0.01] (Fig. 1A), CCCP-induced state respiration
(uncoupled state) [F(2,9) = 30.413, P b 0.001] (Fig. 1C) and RCR
[F(2,9) = 25.149, P b 0.001] (Fig. 1D), but not state 4 (Fig. 1B), inmito-
chondria supported by glutamate plus malate. In contrast, sulﬁte did not
altermitochondrial respirationwhen succinate,α-ketoglutarate or pyru-
vate plus malate were used as substrates. Moreover, thiosulfate did not
affect mitochondrial oxygen consumption regardless of the substrate
used (results not shown). Fig. 1E shows a representative respiration
curve demonstrating the transition from state 3 to state 4. This ﬁgure al-
lows a direct calculation of state 3, state 4 and RCR.
3.2. Sulﬁte inhibits GDH and MDH activities in brain mitochondria
We assessed the effect of sulﬁte on the activities of GDH, MDH and
α-KGDH in mitochondrial preparations in order to evaluate whether
the inhibition of brain mitochondrial respiration caused by this metab-
olite in the presence of glutamate plus malate as substrates could be ex-
plained by the impairment of glutamate and malate oxidation. Figs. 2A
and B show that sulﬁte inhibited GDH [F(4,15) = 3.163, P b 0.05] and
MDH [F(4,25) = 17.192, P b 0.001] activities. In contrast, α-KGDH activ-
ity was not altered by sulﬁte (Fig. 2C).
SinceMDHwasmore vulnerable thanGDH to sulﬁte effects,we eval-
uated the inﬂuence of thismetabolite on the activity of a commercial so-
lution of MDH. It can be observed that sulﬁte inhibited the activity of
puriﬁed MDH and that the antioxidants catalase (CAT) and melatonin
(MEL), as well as the reductant agent DTT attenuated this effect[F(4,18) = 38.711, P b 0.001] (Fig. 3). Our results showing that antioxi-
dants and DTT partially prevented this effect suggest that reactive spe-
cies and modiﬁcation of thiol groups on the enzyme, respectively, are
involved in the inhibition of MDH activity.3.3. Sulﬁte induces mitochondrial membrane potential (ΔΨm) dissipation
and swelling in the presence of Ca2+ in brain mitochondria supported by
glutamate plus malate
The next set of experiments was carried out to investigate the effect
of sulﬁte on ΔΨm in state 4 respiring mitochondria in the absence or
presence of Ca2+ (10–30 μM), using glutamate plus malate as sub-
strates. It can be seen in Fig. 4A that sulﬁte caused a progressive reduc-
tion of ΔΨm after the addition of increasing Ca2+ concentrations. In
contrast, no effect could be observed in the absence of Ca2+ in the incu-
bation medium. We then evaluated the effect of raising sulﬁte concen-
trations (10–500 μM) on ΔΨm in the presence of Ca2+ (20 μM) and
observed that sulﬁte dissipates ΔΨm in a dose-dependent manner
(Fig. 4B). RR, a potent inhibitor of the mitochondrial Ca2+ uptake, was
able to prevent sulﬁte-inducedΔΨm reduction, implying that sulﬁte ef-
fects are dependent on the entrance of Ca2+ into themitochondria. Fur-
thermore, the decrease of ΔΨm provoked by sulﬁte in the presence of
Ca2+ was prevented by CsA and ADP, inhibitors of MPT (Fig. 4C).
Fig. 4. Effect of sulﬁte onmitochondrialmembrane potential (ΔΨm)using brainmitochondria supported by glutamate plusmalate in the absence or presenceof Ca2+. (A) Sulﬁte (500 μM)
(trace b) was added at the beginning of incubation to the reaction medium containing the mitochondrial preparations (0.5 mg protein·mL−1). Increasing concentrations of Ca2+ (0 μM,
trace b; 10 μM, trace c; 20 μM, trace d; 30 μM, trace e)were added 50 s afterwards. (B) Increasing concentrations of sulﬁte (10 μM, trace b; 100 μM, trace c; 250 μM, trace d; 500 μM, trace e)
were added at the beginning of incubation to the reactionmediumcontaining themitochondrial preparations (0.5mg protein·mL−1). Ca2+ (20 μM)was added 50 s afterwards. (C) Sulﬁte
(500 μM) (trace b) was added at the beginning of incubation to the reaction medium containing the mitochondrial preparations (0.5 mg protein·mL−1). Ca2+ (20 μM) was added 50 s
afterwards. In some experiments, the mitochondrial preparations were incubated with sulﬁte plus ruthenium red (RR; 1 μM; trace c), cyclosporine A (CsA; 1 μM; trace d) or
ADP (300 μM; trace e). Control (trace a) in graphic A was performed in the absence of Ca2+ and sulﬁte, whereas controls (traces a) in graphics B and C were performed in
the presence of Ca2+ (20 μM) and did not contain sulﬁte. FCCP (1 μM) was added at the end of the experiment, as indicated. Traces are representative of three independent ex-
periments and express ﬂuorescence arbitrary units (FAU).
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inner membrane permeabilization due to MPT pore opening with
sulﬁte-induced ΔΨm decrease, we measured mitochondrial swelling
by following light scattering changes. It was veriﬁed that sulﬁte caused
swelling in the presence of Ca2+ in brain mitochondria and that this ef-
fect was fully prevented by RR, CsA and ADP, reinforcing therefore the
induction of MPT by sulﬁte (Fig. 5A). In contrast, sulﬁte did not induce
swelling in mitochondrial preparations from rat liver, implying that
brain is more vulnerable to the toxic effects of this metabolite (Fig. 5B).
3.4. Sulﬁte reduces Ca2+ retention capacity in brain mitochondria
supported by glutamate plus malate
We then investigated the inﬂuence of sulﬁte on mitochondrial Ca2+
retention, sinceMPT induction leads to a rapid release of Ca2+ frommi-
tochondria. As shown in Fig. 6, sulﬁte reduced the mitochondrial Ca2+
retention capacity compared with control mitochondria supported by
glutamate plus malate. Furthermore, CsA and ADP prevented this effect,Fig. 5.Effect of sulﬁte onmitochondrial swellingusing (A)brain or (B) livermitochondria suppo
at the beginning of incubation to the reactionmedium containing themitochondrial preparatio
themitochondrial preparationswere incubatedwith sulﬁte plus ruthenium red (RR; 1 μM; trac
performed in the presence of Ca2+ (40 μM) and did not contain sulﬁte. Alamethicin (Alam; 40
resentative of three independent experiments and express ﬂuorescence arbitrary units (FAU).indicating the involvement of MPT induction in themitochondrial Ca+2
handling disruption induced by sulﬁte.
3.5. Sulﬁte decreasesmitochondrial matrix NAD(P)Hpool in the presence of
Ca2+ in brain mitochondria supported by glutamate plus malate
Sulﬁte reducedNAD(P)H ﬂuorescence in the presence of Ca2+ inmi-
tochondria supported by glutamate plus malate (Fig. 7), suggesting
that this metabolite decreased NAD(P)H pool due either to a oxidation
of the reduced equivalents or their loss from the matrix. CsA, ADP and
RR were able to prevent this effect, suggesting the involvement of
MPT induction.
3.6. NEM prevents sulﬁte-induced swelling in the presence of Ca2+ in brain
mitochondria supported by glutamate plus malate
In the next step, we evaluated whether compounds reported to in-
hibit the MPT, such as phospholipase A2 inhibitors (TFZ, CP and QUIN)rted by glutamate plusmalate in thepresenceof Ca2+. Sulﬁte (500 μM) (traceb)was added
ns (0.5mg protein·mL−1). Ca2+ (40 μM)was added 50 s afterwards. In some experiments,
e c), cyclosporine A (CsA; 1 μM; trace d) or ADP (300 μM; trace e). Controls (traces a) were
μg·mg of protein−1) was added at the end of the experiment, as indicated. Traces are rep-
Fig. 6. Effect of sulﬁte onmitochondrial Ca2+ retention capacity using brain mitochondria
supported by glutamate plus malate in the presence of Ca2+. Sulﬁte (500 μM) (trace b)
was added at the beginning of incubation to the reaction medium containing ADP
(30 μM) and the mitochondrial preparations (0.5 mg protein·mL−1). Ca2+ (20 μM) was
added afterwards. In some experiments, the mitochondrial preparations were incubated
with sulﬁte and cyclosporine A (CsA; 1 μM) plus ADP (300 μM; trace d). Controls (traces
a and c)were performed in the presence of 20 μMCa2+ and did not contain sulﬁte. Traces
are representative of three independent experiments and express ﬂuorescence arbitrary
units (FAU).
Fig. 8. Effect of N-ethylmaleimide (NEM; 20 μM) on sulﬁte-induced mitochondrial swell-
ing using brainmitochondria supported by glutamate plusmalate in the presence of Ca2+.
Sulﬁte (500 μM) (trace b) was added at the beginning of incubation to the reaction medi-
um containing themitochondrial preparations (0.5 mg protein·mL−1). Ca2+ (40 μM)was
added 50 s afterwards. In some experiments, the mitochondrial preparations were incu-
bated with sulﬁte plus NEM (trace c). Control (trace a) was performed in the presence
of Ca2+ (40 μM) and did not contain sulﬁte. Alamethicin (Alam; 40 μg·mg of protein−1)
was added at the end of the experiment, as indicated. Traces are representative of three
independent experiments and express ﬂuorescence arbitrary units (FAU).
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reagent DTT [29,36,37] and the hydrophobic thiol reagent NEM [29,
36–38], could prevent the mitochondrial swelling induced by sulﬁte.
We found that the inhibitors of phospholipase A2, antioxidants and
DTT did not alter this effect (results not shown). In contrast, NEM
prevented sulﬁte-induced swelling in the presence of Ca2+, suggesting
that sulﬁte exerts a direct effect on thiol groups of proteins involved in
MPT pore formation (Fig. 8).3.7. Sulﬁte decreases the content of thiol groups in the presence of Ca2+ in
brain mitochondria supported by glutamate plus malate
Our results also demonstrate that 500 μM sulﬁte signiﬁcantly de-
creased the content of thiol groups in the presence of Ca2+ in brain mi-
tochondria [F(2,11) = 34.591, P b 0.001] (Fig. 9), reinforcing the view
that sulﬁte has a direct effect on these groups. We further observed
that 200 μM NEM decreased this parameter in the same conditions
(positive control) (Fig. 9).3.8. Sulﬁte induces cytochrome c release from brain mitochondria in the
presence of Ca2+
Wemeasured the effect of sulﬁte on cytochrome c release frommi-
tochondria. We found that sulﬁte markedly decreased mitochondrial
cytochrome c immunocontent [F(2,6)= 119.171, P b 0.001] (Fig. 10), in-
dicating an increase of cytochrome c release from themitochondria. CsA
attenuated this effect, implying that it occurred due to sulﬁte-induced
MPT in the presence of Ca2+.Fig. 7. Effect of sulﬁte on mitochondrial NAD(P)H content using brain mitochondria sup-
ported by glutamate plus malate in the presence of Ca2+. Sulﬁte (500 μM) (trace b) was
added at the beginning of incubation to the reactionmedium containing themitochondri-
al preparations (0.5mg protein·mL−1). Ca2+ (20 μM)was added 50 s afterwards. In some
experiments, the mitochondrial preparations were incubated with sulﬁte plus ruthenium
red (RR; 1 μM; trace c), cyclosporine A (CsA; 1 μM; trace d) or ADP (300 μM; trace e). Con-
trol (trace a) was performed in the presence of Ca2+ (20 μM) and did not contain sulﬁte.
FCCP (1 μM)was added at the end of the experiment, as indicated. Traces are representa-
tive of three independent experiments and express ﬂuorescence arbitrary units (FAU).3.9. Sulﬁte reduces cell viability in cerebral cortex slices
We ﬁnally examined the effect of sulﬁte on cell viability in cere-
bral cortex slices through MTT reduction in order to check whether
sulﬁte could induce injury to intact cells. We found that sulﬁte signif-
icantly decreased MTT reduction and that CsA prevented this effect
[F(2,10) = 6.566, P b 0.05] (Fig. 11), implying that sulﬁte-mediated
MPT pore opening causes cell injury.4. Discussion
High tissue levels of sulﬁte and thiosulfate are characteristic of iso-
lated SO deﬁciency and molybdenum cofactor deﬁciency. Affected pa-
tients predominantly present neonatal seizures, encephalopathy and
psychomotor retardation, whose pathophysiology is uncertain. Howev-
er, some evidences indicate that mitochondrial dysfunction caused by
the accumulating metabolites may be involved in the neurological dys-
function of these diseases [2,7,12,13,39]. In this particular, it should be
emphasized that lactic acidemia has been described in affected patients
[2,7,39]. Therefore, in the present studywe investigated the effect of sul-
ﬁte and thiosulfate on brain mitochondrial homeostasis.
We ﬁrst veriﬁed that sulﬁte, but not thiosulfate, decreased oxygen
consumption in state 3 and uncoupled respiration in mitochondria sup-
ported by glutamate plus malate, that are electron donors of complex I,
but notwith succinate, which donates electrons to complex II, and other
NADH-linked substrates (α-ketoglutarate or pyruvate plusmalate). OurFig. 9. Effect of sulﬁte on thiol group content in brainmitochondria supported by glutamate
plus malate in the presence of Ca2+. Sulﬁte (500 μM) and Ca2+ (40 μM)were added to the
incubation medium containing the mitochondrial preparations (0.5 mg protein·mL−1).
In some experiments, the mitochondrial preparations were incubated with N-
ethylmaleimide (NEM; 200 μM). Values are means ± standard deviation for four to ﬁve
independent experiments (animals) and are expressed as percentage of control (Control:
54.0 ± 2.13 nmol TNB·mg protein−1). ** P b 0.01, *** P b 0.001, compared to control
(Duncan multiple range test).
Fig. 10. Effect of sulﬁte on cytochrome c immunocontent in brain mitochondria sup-
ported by glutamate plus malate in the presence of Ca2+. Sulﬁte (500 μM) and Ca2+
(40 μM) were added to the incubation medium containing the mitochondrial prepa-
rations (0.5 mg protein·mL−1). In some experiments, the mitochondrial preparations
were incubated with sulﬁte plus cyclosporine A (CsA; 1 μM). A representative immuno-
blot of cytochrome c is also displayed. Values are means ± standard deviation for three
to four independent experiments (animals) and are expressed as percentage of control
(Control: 33091 ± 2660 arbitrary units). **P b 0.01, *** P b 0.001, compared to control;
###P b 0.001, compared to sulﬁte (Duncan multiple range test).
Fig. 11. Effect of sulﬁte on cerebral cortex slices viability determined by MTT reduction
assay. Rat cerebral cortex slices were incubated for 3 h in the absence or presence of
500 μM sulﬁte and 1 μM cyclosporine (CsA). Values are mean ± standard deviation for
three to four independent experiments (animals) and are expressed as percentage of con-
trol. *P b 0.05, compared to control (Duncan multiple range test).
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rators [12], showing that sulﬁte causes ATP depletion in PC12 and
Neuro-2a cells. Taken together, these data indicate that sulﬁte-
induced decrease of mitochondrial respiration occurred due to a block-
age of glutamate and/or malate oxidation. We further veriﬁed that sul-
ﬁte inhibited GDH and MDH activities, whereas no alteration was
observed in α-KGDH activity. In the brain, GDH reaction occurs mainly
in the direction of oxidative deamination of glutamate forming NADH
and α-ketoglutarate, which can be oxidized through the Krebs cycle
[40]. MDH, in turn, is a Krebs cycle enzyme and also a component in
the malate-aspartate shuttle system. Therefore, it is presumed that the
mitochondrial respiration impairment caused by sulﬁte may be due to
the inhibition of glutamate and malate oxidation through GDH and
MDH, which causes a decrease in the availability of intermediates of tri-
carboxylic acid cycle and a lack of reduced equivalents to supply the re-
spiratory chain. These ﬁndings are in line with those observed by Zhang
and colleagues [12], who showed that 100 μM sulﬁte, which was the
highest dose tested, moderately inhibits MDH activity andmarkedly di-
minished GDH activity. We further veriﬁed that CAT, MEL and DTT
prevented the inhibition of the activity of puriﬁed MDH caused by sul-
ﬁte. So, it may be presumed that reactive species scavenged by MEL
and CAT are involved in this effect. The fact that DTT also attenuated
this effect suggests that thiol groups on the enzyme are vulnerable to
sulﬁte. However, we cannot ascertainwhether the alterations of the en-
zyme thiol groups are mediated through reactive species or a direct at-
tack of sulﬁte. It should be also noted thatα-aminoadipic semialdehyde
(AASA) dehydrogenase is inhibited in vitro by sulﬁte, leading to in-
creased levels of α-AASA and its cyclic form piperideine-6-carboxylate
(P6C). In this particular, the increase of α-AASA and P6C due to sulﬁte
accumulation could contribute to the pathophysiology of SO deﬁciency,
since P6C acts as a trapping agent of pyridoxal-5-phosphate [41,42].
Next, we observed that sulﬁte decreased the ΔΨm and induced
swelling in brain mitochondria in the presence of Ca2+, but not in the
absence of this cation. In addition, the prevention of these effects by
RR, a potent inhibitor of the mitochondrial Ca2+ uptake [43], supports
the importance of the involvement of Ca2+ in these effects. It is well
known thatmitochondria play a central role in cytosolic Ca2+ buffering,
although an abnormal increase in mitochondrial Ca2+ uptake may in-
duce MPT and lead to apoptosis in different cells [18,44,45]. The MPT
causes a non-selective trafﬁc between the mitochondrial matrix and
the cytosol, allowing the inﬂux of water and substances up to 1.5 kDa
into the matrix and leading to mitochondrial swelling, loss of metabo-
lites (Ca2+, glutathione, NADHandNADPH),ΔΨmcollapse, impairment
of oxidative phosphorylation and ATP synthesis, as well as release of
proapoptotic factors, such as cytochrome c [46–48]. On the other
hand, sulﬁte did not provoke swelling in liver mitochondria, which is
in accordance with the fact that patients with SO deﬁciency do not
present hepatic dysfunction.
Our results also showed that the decrease of ΔΨm elicited by sulﬁte
is due to a non-selective membrane permeabilization caused by MPT
pore opening, since ΔΨm dissipation was accompanied by mitochon-
drial swelling and was inhibited by CsA and ADP. In this particular,
CsA inhibits MPT by binding cyclophilin D, a mitochondrial matrix pro-
tein which has been reported to be a MPT pore modulator through its
interaction with the adenine nucleotide translocator (ANT) [44,49,50].
Furthermore, it is known that adenine nucleotides inhibit MPT pore
through their binding to ANT [18,28]. Our data showing that sulﬁte re-
duced the mitochondrial Ca2+ retention capacity and that this effect
was prevented by CsA plus ADP are also in line with the induction of
MPT pore opening by synergistical effects of sulﬁte and Ca2+.
We further veriﬁed that NEM prevented the mitochondrial swelling
induced by sulﬁte in the presence of Ca2+. NEM is an alkylating agent
that reacts with sulfhydryl groups to form stable thioether bonds. Previ-
ous reports demonstrated that NEMhas access to critical thiol groups on
ANT that regulate the MPT pore opening [37,51,52]. Therefore, our data
showing that NEM prevented the mitochondrial swelling caused by
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groups, which increases the probability of pore opening. This is rein-
forced by our ﬁndings showing that sulﬁte decreased the content of
thiol groups in brain mitochondria and is in accordance with other evi-
dences demonstrating that sulﬁte reacts directly with sulfhydryl groups
[1]. On the other hand, since antioxidants did not prevent sulﬁte-
induced swelling, it may be suggested that the reactive species generat-
ed from thismetabolite do not alter critical groups involved inMPT pore
opening. Indeed, it has been reported that other compounds, such as
acetoacetate, phenylarsine oxide and 4,4′-diisothiocyanatostilbene-
2,2′-disulfonic acid, are able to induce MPT independently of reactive
species [29,37,38,51]. It is also of note that Costantini and collaborators
[36] reported that at least two distinct sites containing thiol groups
modulate MPT and that one site is insensitive to reductants like DTT.
Sulﬁte also diminished the mitochondrial matrix NAD(P)H levels in
the presence of Ca2+. The loss of themitochondrial pool of pyridine nu-
cleotides could be explained by a release of NAD(P)H from the mito-
chondria through the MPT pore, which can lead to the impairment of
mitochondrial redox homeostasis. In fact, the matrix NAD(P)H pool de-
crease elicited by sulﬁte was inhibited by CsA and ADP, implying that
this effect was caused by MPT induction.
We also found that sulﬁte reduced mitochondrial cytochrome c
immunocontent, which could be related to the MPT induced by this
compound. In this regard, the release of cytochrome c from the mito-
chondrial intermembrane space into the cytosol typically accompanies
the osmotic swelling and the physical rupture of the mitochondrial
outermembrane provoked byMPT [53,54]. The observation that the de-
crease of mitochondrial cytochrome c immunocontent was prevented
by CsA supports this hypothesis. The release of cytochrome c frommito-
chondria into the cytosol plays a key role in the apoptosis induction by
forming the apoptosome complex with Apaf-1 and procaspase-9 and
initiating the caspase cascade [48,55]. Thus, our results suggest that sul-
ﬁtemay induce apoptosis by promotingMPT in the presence of Ca2+. In
line with this, we veriﬁed that sulﬁte decreased cell viability in cerebral
cortex and that CsA, an inhibitor of MPT pore opening, prevented this
effect.
It is noteworthy that neurons are more susceptible to the induction
ofMPT due to increases in intracellular Ca2+ levels after NMDA receptor
overstimulation (excitotoxicity). In this context, it should be empha-
sized that S-sulfocysteine, ametabolite structurally similar to glutamate
generated from sulﬁte and free cysteine, is able to activate NMDA recep-
tors [56,57], leading to high Ca2+ inﬂux. Furthermore, the inhibition of
GDH by sulﬁte could lead to high levels of glutamate in the synaptic
cleft, contributing to the raise of intracellular Ca2+ concentrations. In
addition, energy metabolism dysfunction induced by sulﬁte could also
play an important role in Ca2+ dyshomeostasis through the impairment
of Ca2+ removal systems. Therefore, it is hypothesized that a failure in
Ca2+ handling by the mitochondrion is potentially involved in the neu-
ropathology of SO deﬁciency.
In conclusion, our study provides for the ﬁrst time evidence that sul-
ﬁte acts synergistically with Ca2+ inducing MPT in the brain mediated
by a direct attack of sulﬁte on critical protein cysteinyl groups of the
transition pore. Therefore, it is presumed that bioenergetic dysfunction
andMPT inductionmay be important pathomechanisms underlying the
pathogenesis of the neurological dysfunction observed in SO deﬁcient
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